What is the recommended intravenous dose and dosing interval of Buscopan (hyoscine butylbromide) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Buscopan (Hyoscine Butylbromide) IV Dosing for Adults

For adults, administer Buscopan 20 mg intravenously as a single dose, which can be repeated if necessary based on clinical response.

Standard Dosing

  • Initial dose: 20 mg IV administered as a slow intravenous injection 1
  • This represents the standard dose validated across multiple clinical contexts including gastrointestinal imaging and pain management 2, 3

Dosing Frequency

  • Single dose administration is typically sufficient for most indications 1
  • Repeat dosing: If needed, the dose can be repeated, though specific intervals are not rigidly defined in the FDA labeling 1
  • In clinical practice, the drug has been safely administered with consideration for its duration of action, which shows effects lasting approximately 15-30 minutes for gastrointestinal smooth muscle relaxation 4, 2

Administration Technique

  • Administer as a slow IV injection to minimize potential cardiovascular effects 1
  • The intravenous route is more effective than oral administration, which has been shown to be ineffective for achieving adequate smooth muscle relaxation 3

Clinical Context

The 20 mg IV dose has been extensively studied and validated:

  • Gastrointestinal imaging: 20 mg IV produces superior gastroduodenal distension compared to lower doses (5 mg or 10 mg), with 5 mg showing unacceptable results in nearly half of examinations 2
  • Pain management: Single 20 mg IV doses have been evaluated for various pain conditions including dysmenorrhea and gastroenteritis, though efficacy varies by indication 5, 6, 7

Important Caveats

  • Anticholinergic effects are expected and transient, including pupillary dilation, dry mouth, and temporary reduction in gut motility 1
  • Contraindications include glaucoma, prostatic hypertrophy, and mechanical gastrointestinal obstruction (standard anticholinergic precautions) 1
  • The drug is generally well-tolerated with minimal serious adverse events reported in clinical trials 5, 6, 7
  • Onset of action occurs within minutes of IV administration, with peak effects at 10-15 minutes 1, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.